Traumatic brain injuries treatment sales will grow through 2036, led by drugs at 27.5% of the treatment type segment in 2026, driven by rising incidence of traumatic brain injuries and advancing treatment protocols. The market was valued at USD 2.10 billion in 2025 and is expected to be worth USD 4.61 billion by 2036.